303 Kwashiorkor – a clinical manifestation of cystic fibrosis
نویسندگان
چکیده
منابع مشابه
Cystic fibrosis presenting as kwashiorkor in a Sri Lankan infant.
Growth failure is a common presentation of patients with pancreatic insufficient cystic fibrosis. However, full blown kwashiorkor is extremely rare. Cystic fibrosis is also considered to be rare in the South Asian population. This report describes a Sri Lankan infant with cystic fibrosis who presented with clinical features of severe kwashiorkor.
متن کاملCystic fibrosis presenting as kwashiorkor with florid skin rash.
Two infants with a florid erythematous rash and generalised oedema, hypoalbuminaemia, and anaemia were found to have cystic fibrosis. This rare presentation is associated with false negative sweat tests, delays in diagnosis, and a considerable mortality. It is proposed that this presentation represents a manifestation of kwashiorkor secondary to malabsorption. The recognition that these infants...
متن کاملPancreatic cystosis: A rare pancreatic manifestation in cystic fibrosis
Cystic fibrosis (CF) is a multisystemic, autosomal recessive disorder that predominantly affects infants, children, and young adults. Manifestations of CF involve the lung and gastrointestinal tract, including the pancreas. Pancreatic cystosis is a rare condition typically seen in CF during the second decade of life. It has characteristic magnetic resonance imaging (MRI) and ultrasound (US) fea...
متن کاملCLINICAL REVIEW Cystic fibrosis
Over 7000 people have cystic fibrosis in the United Kingdom. It is the commonest genetically inherited disease in white populations (1 in 2500 newborns), although it is increasingly recognised as being important in non-white populations. However, most general practitioners have only one or two patients on their list, and as management generally takes place in specialist centres, many general pa...
متن کاملClinical trials in cystic fibrosis.
In patients with cystic fibrosis (CF), clinical trials are of paramount importance. Here, the current status of drug development in CF is discussed and future directions highlighted. Methods for pre-clinical testing of drugs with potential activity in CF patients including relevant animal models are described. Study design options for phase II and phase III studies involving CF patients are pro...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Cystic Fibrosis
سال: 2014
ISSN: 1569-1993
DOI: 10.1016/s1569-1993(14)60438-0